CINECA IRIS Institutional Research Information System

TUCCINARDI, TIZIANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 23.906
AS - Asia 11.185
EU - Europa 9.339
SA - Sud America 2.000
Continente sconosciuto - Info sul continente non disponibili 723
AF - Africa 434
OC - Oceania 21
Totale 47.608
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 23.190
IT - Italia 3.909
SG - Singapore 3.498
CN - Cina 2.939
HK - Hong Kong 1.782
BR - Brasile 1.652
SE - Svezia 1.136
VN - Vietnam 1.069
DE - Germania 862
BG - Bulgaria 670
FR - Francia 552
CA - Canada 509
GB - Regno Unito 473
TR - Turchia 442
FI - Finlandia 391
RU - Federazione Russa 354
IN - India 311
KR - Corea 247
UA - Ucraina 235
JP - Giappone 202
AT - Austria 195
BD - Bangladesh 113
CH - Svizzera 113
NL - Olanda 105
AR - Argentina 101
IQ - Iraq 86
MX - Messico 78
CI - Costa d'Avorio 70
ID - Indonesia 69
BE - Belgio 67
ZA - Sudafrica 65
MA - Marocco 62
CO - Colombia 60
PK - Pakistan 59
EC - Ecuador 55
UZ - Uzbekistan 52
ES - Italia 50
PL - Polonia 48
SA - Arabia Saudita 46
SN - Senegal 43
VE - Venezuela 42
NG - Nigeria 34
CZ - Repubblica Ceca 31
EG - Egitto 31
PH - Filippine 30
JM - Giamaica 28
IR - Iran 27
TN - Tunisia 27
KE - Kenya 23
TW - Taiwan 23
DZ - Algeria 22
GR - Grecia 22
UY - Uruguay 22
PY - Paraguay 21
TT - Trinidad e Tobago 21
CR - Costa Rica 20
IL - Israele 20
CL - Cile 18
PE - Perù 18
AU - Australia 17
MY - Malesia 17
AE - Emirati Arabi Uniti 16
IE - Irlanda 16
JO - Giordania 16
KZ - Kazakistan 16
NP - Nepal 16
RO - Romania 15
ET - Etiopia 14
HN - Honduras 11
HU - Ungheria 11
LB - Libano 11
PT - Portogallo 11
AO - Angola 10
AL - Albania 9
DO - Repubblica Dominicana 9
LT - Lituania 9
AZ - Azerbaigian 8
GE - Georgia 8
PR - Porto Rico 8
TH - Thailandia 8
BB - Barbados 7
BY - Bielorussia 7
SY - Repubblica araba siriana 7
BA - Bosnia-Erzegovina 6
BJ - Benin 6
BO - Bolivia 6
KW - Kuwait 6
PA - Panama 6
PS - Palestinian Territory 6
KG - Kirghizistan 5
OM - Oman 5
RS - Serbia 5
SK - Slovacchia (Repubblica Slovacca) 5
AM - Armenia 4
BH - Bahrain 4
DK - Danimarca 4
EU - Europa 4
GT - Guatemala 4
GY - Guiana 4
HR - Croazia 4
Totale 46.801
Salva come PNG Salva come JPEG
Città #
Ashburn 2.478
Woodbridge 2.305
Singapore 2.018
Fairfield 1.778
Ann Arbor 1.748
Hong Kong 1.745
Houston 1.479
San Jose 1.296
Dallas 1.194
Chandler 1.012
Serra 988
Santa Clara 942
Milan 792
Seattle 754
Sofia 668
Shanghai 665
Beijing 626
Wilmington 607
Cambridge 580
New York 493
Council Bluffs 464
Boardman 351
Los Angeles 348
Princeton 336
Hefei 327
Ottawa 327
Jacksonville 288
Lauterbourg 253
Izmir 252
Lawrence 248
Ho Chi Minh City 240
Seoul 223
Medford 217
Nanjing 183
Tokyo 172
Hanoi 166
São Paulo 163
Munich 155
Vienna 153
Pisa 148
Dong Ket 146
Des Moines 137
Helsinki 133
Redondo Beach 133
Rome 131
Istanbul 130
London 130
Marseille 125
Florence 122
Buffalo 114
San Diego 105
Dearborn 95
Boulder 93
Columbus 87
Redwood City 87
Frankfurt am Main 86
Nanchang 84
Lucca 82
The Dalles 81
Bern 78
Chicago 75
Abidjan 69
Rio de Janeiro 65
Orem 62
Turku 59
Belo Horizonte 56
Ogden 54
Livorno 51
Dakar 43
San Francisco 43
Brussels 42
Jüchen 42
Chennai 41
Tashkent 41
Düsseldorf 36
Hebei 36
Kunming 36
Toronto 36
Amsterdam 35
Casablanca 35
Guangzhou 35
Montreal 35
Nuremberg 35
Baghdad 34
Washington 34
Lagos 33
Norwalk 33
Phoenix 33
Falls Church 32
Atlanta 31
Brasília 31
Dhaka 31
Changsha 30
Shenyang 30
Zurich 30
Bremen 29
Pune 29
Da Nang 28
Denver 28
Hangzhou 28
Totale 32.947
Salva come PNG Salva come JPEG
Nome #
4-Aryliden-2-methyloxazol-5(4H)-one as a new scaffold for selective reversible MAGL inhibitors 332
Anticancer activity of euplotin C, isolated from the marine ciliate euplotes crassus, against human melanoma cells 289
GLUT1 and LOX inhibitors as perspective anticancer agents tackling glucose avidity and ECM remodeling in tumors 276
Phenylpropanoids and flavonoids from Phlomis kurdica as inhibitors of human lactate dehydrogenase. 266
Tenebrio molitor reared on different substrates: is it gluten free? 264
Receptor-based virtual screening evaluation for the identification of estrogen receptor β ligands 263
Human carbonyl reductase 1 as efficient catalyst for the reduction of glutathionylated aldehydes derived from lipid peroxidation 263
New activators of SIRT1 enzyme for the treatment of cardiovascular and cardiometabolic pathologies 256
The TRPA1 channel mediates the analgesic action of dipyrone and pyrazolone derivatives 252
Synthesis and biological evaluation of non-glucose glycoconjugated N-hydroyxindole class LDH inhibitors as anticancer agents 241
Aldose reductase differential inhibitors in green tea 240
Identification of Lactate Dehydrogenase 5 Inhibitors using Pharmacophore- Driven Consensus Docking 237
1,8-Naphthyridin-4-one derivatives as new ligands of A2A adenosine receptors. 233
Identification of the first synthetic allosteric modulator of the CB2receptors and evidence of its efficacy for neuropathic pain relief 230
Synthesis and Biological Evaluation of New Glycoconjugated LDH Inhibitors as Anticancer Agents 230
Growth performances, chemical composition, and microbiological loads of mealworm reared with brewery spent grains and bread leftovers 227
Polypharmacological profile of 1,2-dihydro-2-oxo-pyridine-3-carboxamides in the endocannabinoid system 227
Synthesis and antitumor evaluation of 1,8-naphthyridine-2-(1H)-on-3carboxamide derivatives as CB2 selective agonists 226
Bifunctional Inhibitors as a New Tool To Reduce Cancer Cell Invasion by Impairing MMP-9 Homodimerization 226
Nuovi attivatori dell’enzima SIRT1 per il trattamento delle patologie cardiovascolari e cardiometaboliche 226
Reliability analysis and optimization of the consensus docking approach for the development of virtual screening studies 226
Development of terphenyl-2-methyloxazol-5(4H)-one derivatives as selective reversible MAGL inhibitors 223
Optimization of a Benzoylpiperidine Class Identifies a Highly Potent and Selective Reversible Monoacylglycerol Lipase (MAGL) Inhibitor 223
Structural optimization of 4-chlorobenzoylpiperidine derivatives for the development of potent, reversible and selective monoacylglycerol lipase (MAGL) inhibitors 222
Discovery of 1,5-Diphenylpyrazole-3-Carboxamide Derivatives as Potent, Reversible, and Selective Monoacylglycerol Lipase (MAGL) Inhibitors 220
Sirtuin 1-Activating Compounds: Discovery of a Class of Thiazole-Based Derivatives 217
Discovery of long-chain salicylketoxime derivatives as monoacylglycerol lipase (MAGL) inhibitors 216
Rational Development of MAGL Inhibitors 213
Identification of a new STAT3 dimerization inhibitor through a pharmacophore-based virtual screening approach 212
Synthesis of Anthranylaldoxime Derivatives as Estrogen Receptor Ligands and Computational Prediction of Binding Modes 210
Synthesis and AT1 affinity evaluation of benzamidophenyl analogs of known AT1 receptor ligands with similar aromatic skeleton 210
Synthesis of stable analogues of geranylgeranyl diphosphate possessing a (Z,E,E)-geranylgeranyl side chain, docking analysis, and biological assays for prenyl protein transferase inhibition 209
Historical perspective of tumor glycolysis: a century with Otto Warburg 208
Identification of new FYN kinase inhibitors using a FLAP-based approach 206
Salicylaldoxime derivatives as new leads for the development of carbonic anhydrase inhibitors 205
Salicylaldoximes and anthranylaldoximes as alternatives to phenol-based estrogen receptor ligands 205
Salicylaldoximes and anthranylaldoximes as alternatives to phenol-based estrogen receptor ligands 204
Exosite inhibition of ADAMTS-5 by a glycoconjugated arylsulfonamide 204
The Extra-Virgin Olive Oil Polyphenols Oleocanthal and Oleacein Counteract Inflammation-Related Gene and miRNA Expression in Adipocytes by Attenuating NF-κB Activation 204
D3 dopamine receptor subtype: which binding modes for such different ligands?, 203
Rational design, synthesis, biological evaluation and labelling of selective cannabinoid CB2 receptor agonists as anticancer agents 203
Design, synthesis, ADME and biological evaluation of benzylpiperidine and benzylpiperazine derivatives as novel reversible monoacylglycerol lipase (MAGL) inhibitors 202
Discovery of N-Hydroxyindole-Based Inhibitors of Human Lactate Dehydrogenase Isoform a (LDH-A) as Starvation Agents against Cancer Cells 201
Dual Targeting of the Warburg Effect with a Glucose-Conjugated Lactate Dehydrogenase Inhibitor 201
COMPOUNDS INHIBITING THE ENZYME LACTATE DEHYDROGENASE (LDH), PHARMACEUTICAL COMPOSITIONS AND USES THEREOF 201
Antiproliferative oxime derivatives that inhibit glucose transporter 1 (GLUT1) in cancer cells 200
An overview of recent developments in GPCR modelling: methods and validation 200
Stereoselectivity of aldose reductase in the reduction of glutathionyl-hydroxynonanal adduct 200
Dual Inhibitors of Matrix Metalloproteinases and Carbonic Anhydrases: Iminodiacetyl-Based Hydroxamate-Benzenesulfonamide Conjugates 198
Characterization of the Saffron Derivative Crocetin as an Inhibitor of Human Lactate Dehydrogenase 5 in the Antiglycolytic Approach against Cancer 198
5-Amino-2-phenyl[1,2,3]triazolo[1,2-a][1,2,4]benzotriazin-1-one: a Versatile Scaffold to Obtain Potent and Selective A3 Adenosine Receptor Antagonists 196
Computationally driven discovery of phenyl(piperazin-1-yl)methanone derivatives as reversible monoacylglycerol lipase (MAGL) inhibitors 196
Design, Synthesis, Biological Evaluation, and NMR Studies of a New Series of Arylsulfones As Selective and Potent Matrix Metalloproteinase-12 Inhibitors 195
Development of a receptor-based 3D-QSAR study for the analysis of MMP2, MMP3, and MMP9 inhibitors 193
N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity 193
Modification on the 1,2-dihydro-2-oxo-pyridine-3-carboxamide core to obtain multi-target modulators of endocannabinoid system 193
D3 dopamine receptor subtype: which binding modes for such different ligands? 192
MolBook UNIPI─Create, Manage, Analyze, and Share Your Chemical Data for Free 191
New monoaryl-salicylaldoximes with improved ERbeta-selective agonist potency 191
Computational studies of EGFR inhibitors: Docking, 3D-QSAR analysis and virtual screening evaluation 190
Nuovi agenti antivirali a struttura N-idrossiindrol-carbossamidica 189
VenomPred 2.0: A Novel In Silico Platform for an Extended and Human Interpretable Toxicological Profiling of Small Molecules 189
Former foodstuff products in Tenebrio molitor rearing: Effects on growth, chemical composition, microbiological load, and antioxidant status 189
Dissecting the Activity of Catechins as Incomplete Aldose Reductase Differential Inhibitors through Kinetic and Computational Approaches 188
Amber force field implementation, molecular modelling study, synthesis and MMP-1/MMP-2 inhibition profile of (R)- and (S)-N-hydroxy-2-(N-isopropoxybiphenyl-4-ylsulfonamido)-3-methylbutanamides 188
Highly Selective Salicylketoxime-Based Estrogen Receptor β Agonists Display Antiproliferative Activities in a Glioma Model 188
Cyclic Ketoximes as Estrogen Receptorβ Selective Agonists 188
Design, Synthesis, and Evaluation of GLUT Inhibitors 188
Liposomal delivery of a Pin1 inhibitor complexed with cyclodextrins as new therapy for high-grade serous ovarian cancer 188
Olivetol- and Resorcinol-Anandamide “hybrids”: design, synthesis, binding and molecular modeling of potent cannabinoid receptor ligands 185
Design of transthyretin amyloidosis inhibitors: A docking and virtual screening approach 184
Assessing the differential action on cancer cells of LDH-A inhibitors based on the N-hydroxyindole-2-carboxylate (NHI) and malonic (Mal) scaffolds 184
Effects of different blanching treatments on microbiological profile and quality of the mealworm (Tenebrio molitor) 184
Different Binding Modes of Structurally Diverse Ligands for Human D3DAR 183
N-Hydroxyindole-based inhibitors of lactate dehydrogenase against cancer cell proliferation 183
Selective and potent agonists for estrogen receptor beta derived from molecular refinements of salicylaldoximes 183
Design, synthesis and biological evaluation of bifunctional inhibitors of membrane type 1 matrix metalloproteinase (MT1-MMP) 183
Design, Synthesis and biological evaluation of new 1,8-naphthyridin-4(1h)-on-3-carboxamide and quinolin-4(1h)-on-3-carboxamide derivatives as CB2 selective agonists 182
Cannabinoid CB2/CB1 Selectivity. Receptor Modeling and Automated Docking Analysis 182
N-O-Isopropyl Sulfonamido-Based Hydroxamates: Design, Synthesis and Biological Evaluation of Selective Matrix Metalloproteinase-13 Inhibitors as Potential Therapeutic Agents for Osteoarthritis 181
Development of a Fingerprint-Based Scoring Function for the Prediction of the Binding Mode of Carbonic Anhydrase II Inhibitors 181
Continued exploration of 1,2,4-oxadiazole periphery for carbonic anhydrase-targeting primary arene sulfonamides: Discovery of subnanomolar inhibitors of membrane-bound hCA IX isoform that selectively kill cancer cells in hypoxic environment 181
Selective activators of estrogen receptor beta based on the aldoxime and ketoxime scaffolds 180
Immunomodulatory properties of 1,2-dihydro-4-hydroxy-2-oxo-1,8-naphthyridine-3-carboxamide derivative VL15 180
Antibacterial and Hypoglycemic Diterpenoids from Salvia chamaedryoides 180
Design, synthesis, binding, and molecular modeling studies of new potent ligands of cannabinoid receptors 178
Computational Studies on Translocator Protein (TSPO) and its Ligands 178
Synthesis of sulfonamide-containing N-hydroxyindole-2-carboxylates as inhibitors of human lactate dehydrogenase-isoform 5 178
Novel aminopteroil-sulfonamide derivatives as inhibitors of dihydrofolate reductase and carbonic anhydrase, with potential anti tumor activity 177
Reversible Monoacylglycerol Lipase Inhibitors: Discovery of a New Class of Benzylpiperidine Derivatives 176
Natural compounds as inhibitors of lactate dehydrogenase 176
Oxime-based inhibitors of glucose transporter 1 displaying antiproliferative effects in cancer cells 175
Interactions of the carrier ligands of antidiabetic metal complexes with human serum albumin: A combined spectroscopic and separation approach with molecular modeling studies 174
Salicylketoximes that target glucose transporter 1 restrict energy supply to lung cancer cells 174
A new development of matrix metalloproteinase inhibitors: twin hydroxamic acids as potent inhibitors of MMPs 173
Arylsulfonamide derivatives as metalloproteases inhibitors and their preparation, pharmaceutical compositions and use in the treatment of degenerative disorders 173
Aryl-sulphonamidic dimers as metalloproteases inhibitors 172
Analysis of Human Carbonic Anhydrase II: Docking Reliability and Receptor-Based 3D-QSAR Study 172
Structure-Activity Relationship Studies of a New Series of Imidazo2,1-fpurinones as Potent and Selective A3 Adenosine Receptor Antagonists 172
Binding investigation and preliminary optimisation of the 3-amino-1,2,4-triazin-5(2H)-one core for the development of new Fyn inhibitors 172
Totale 20.409
Salva come PNG Salva come JPEG
Categoria #
all - tutte 133.378
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 133.378
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.064 0 252 104 182 485 480 107 173 108 100 180 893
2022/20233.485 437 451 287 308 367 476 50 231 588 35 184 71
2023/20243.045 353 327 338 217 470 486 181 78 52 75 120 348
2024/20259.475 82 341 156 507 767 821 791 531 994 1.223 1.096 2.166
2025/202611.646 681 1.483 1.573 1.271 975 938 1.586 614 706 873 556 390
2026/20271.225 437 788 0 0 0 0 0 0 0 0 0 0
Totale 47.608